CRIR Workshop series #2: Discussion Activity : Transition-Teva-Intégration Emploi | September 28, 2022 - CRIR
Teva Pharma Trends Lower Ahead Of A Key Shareholder Meeting This Week (NYSE: TEVA) | Seeking Alpha
Teva launches AJOVY for the treatment of migraine with the YpsoMate autoinjector from Ypsomed - Ypsomed - Group
Teva Reports Fourth Quarter and Full Year 2021 Financial Results | Business Wire
Teva Reports Fourth Quarter and Full Year 2021 Financial Results | Business Wire
TEVA PHARMACEUTICAL INDUSTRIES LIMITED : Historical Intraday Market Prices | TEVA | US8816242098 | MarketScreener
Teva Pharmaceutical: Investment Opportunity During Fed Rate Hike (NYSE:TEVA) | Seeking Alpha
Teva Ramps Up Sales With Medis, Respiratory Units - Bloomberg
Teva Canada Announces New Autoinjector for AJOVY® for the Preventive Treatment of Migraine in Adults
Teva to pay $54M to settle whistleblower lawsuit - Philadelphia Business Journal
Teva Pharmaceutical Industries Ltd's (ADR) (TEVA) GmbH and Alder BioPharmaceuticals Form Global License Agreement
Analyst Ratings for Teva Pharmaceutical Indus | Markets Insider
Teva Pharmaceutical Industries Limited 2022 Q3 - Results - Earnings Call Presentation (NYSE:TEVA) | Seeking Alpha
DEF 14A
Teva Pharmaceuticals Agrees To $85 Million Settlement With Oklahoma In Opioid Case | KPBS Public Media
DEF 14A
Teva Pharmaceutical Stock: Prepare For Takeoff (NYSE:TEVA) | Seeking Alpha
Teva Pharmaceutical (TEVA) Names Richard Francis as New CEO | Nasdaq
Teva Bonds: 8.8% Yield To Maturity Understates Upside | Nasdaq
Teva Pharmaceutical (TEVA) bets on market reopening to regain momentum | AlphaStreet
Teva Pharmaceutical Industries Limited 2022 Q3 - Results - Earnings Call Presentation (NYSE:TEVA) | Seeking Alpha
Israel's TEVA, PERI Tank on Q4 Earnings; IZRL in Focus - TipRanks.com
